This is a StreetInsider.com Premium Only Page

Angion Biomedica (ANGN) –

Apr 10, 2024 04:02 PM Form SC 13D/A Elicio Therapeutics, Filed by: Clal Biotechnology Industries Ltd.

Apr 5, 2024 04:34 PM Form 8-K Elicio Therapeutics, For: Apr 05

Apr 5, 2024 04:30 PM Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR

Mar 29, 2024 03:29 PM Form S-8 Elicio Therapeutics,

Mar 29, 2024 03:27 PM Form S-3 Elicio Therapeutics,

Mar 29, 2024 02:00 PM Form 10-K Elicio Therapeutics, For: Dec 31

Mar 29, 2024 08:36 AM Form 8-K Elicio Therapeutics, For: Mar 29

Mar 29, 2024 08:30 AM Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

Mar 29, 2024 06:04 AM Form D Elicio Therapeutics,

Mar 20, 2024 09:08 PM Form SC 13D/A Elicio Therapeutics, Filed by: Clal Biotechnology Industries Ltd.

Mar 20, 2024 04:37 PM Form SC 13D/A Elicio Therapeutics, Filed by: GKCC, LLC

Mar 20, 2024 04:28 PM Form 4 Elicio Therapeutics, For: Mar 19 Filed by: GKCC, LLC

Mar 18, 2024 08:22 AM Elicio Therapeutics (ELTX) Announces $6.0 Million Private Placement Financing

Mar 18, 2024 08:06 AM Form 8-K Elicio Therapeutics, For: Mar 18

Mar 18, 2024 08:00 AM Elicio Therapeutics Announces $6.0 Million Private Placement Financing

Mar 6, 2024 08:30 AM Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

Feb 5, 2024 06:03 AM Form 4 Elicio Therapeutics, For: Feb 01 Filed by: Haqq Christopher

Feb 5, 2024 06:03 AM Form 4 Elicio Therapeutics, For: Feb 01 Filed by: DeMuth Peter

Feb 5, 2024 06:02 AM Form 4 Elicio Therapeutics, For: Feb 01 Filed by: Connelly Robert

Feb 5, 2024 06:02 AM Form 4 Elicio Therapeutics, For: Feb 01 Filed by: Piekos Brian

Feb 2, 2024 08:51 AM Form 8-K Elicio Therapeutics, For: Feb 01

Jan 17, 2024 08:36 AM Form 8-K Elicio Therapeutics, For: Jan 17

Jan 16, 2024 08:00 AM Form 8-K Elicio Therapeutics, For: Jan 16

Jan 9, 2024 08:11 AM Form 8-K Elicio Therapeutics, For: Jan 09

Jan 5, 2024 04:06 PM Form D Elicio Therapeutics,

Dec 29, 2023 05:06 PM Form 4 Elicio Therapeutics, For: Dec 28 Filed by: ADAMS JULIAN

Dec 29, 2023 05:06 PM Form 4 Elicio Therapeutics, For: Dec 28 Filed by: Chudnovsky Yekaterina

Dec 29, 2023 05:06 PM Form 4 Elicio Therapeutics, For: Dec 28 Filed by: Nissenson Allen

Dec 29, 2023 05:06 PM Form 4 Elicio Therapeutics, For: Dec 28 Filed by: WILSON KAREN J

Dec 29, 2023 05:05 PM Form 4 Elicio Therapeutics, For: Dec 28 Filed by: Ashe Carol Gail

Dec 29, 2023 05:05 PM Form 4 Elicio Therapeutics, For: Dec 28 Filed by: Venkatesan Jay

Dec 29, 2023 05:05 PM Form 4 Elicio Therapeutics, For: Dec 28 Filed by: RUFFOLO ROBERT R

Dec 27, 2023 04:07 PM Form SC 13D/A Elicio Therapeutics, Filed by: Clal Biotechnology Industries Ltd.

Dec 26, 2023 04:30 PM Form 4 Elicio Therapeutics, For: Dec 22 Filed by: GKCC, LLC

Dec 26, 2023 04:25 PM Form SC 13D/A Elicio Therapeutics, Filed by: GKCC, LLC

Dec 22, 2023 09:07 AM Form 8-K Elicio Therapeutics, For: Dec 22

Dec 22, 2023 09:00 AM Elicio Therapeutics Announces $7.0 Million Private Placement Financing

Nov 13, 2023 08:50 AM Form 10-Q Elicio Therapeutics, For: Sep 30

Nov 9, 2023 04:42 PM Form 8-K Elicio Therapeutics, For: Nov 09

Nov 3, 2023 05:10 PM Form 8-K Elicio Therapeutics, For: Nov 03

Oct 20, 2023 07:58 AM Form 8-K Elicio Therapeutics, For: Oct 19

Oct 12, 2023 07:59 AM Form 8-K Elicio Therapeutics, For: Oct 05

Sep 28, 2023 06:01 AM Form 8-K Elicio Therapeutics, For: Sep 27

Sep 7, 2023 08:01 AM Form 8-K Elicio Therapeutics, For: Sep 07

Aug 30, 2023 05:16 PM Form SC 13D/A Elicio Therapeutics, Filed by: Clal Biotechnology Industries Ltd.

Aug 30, 2023 04:34 PM Form 8-K Elicio Therapeutics, For: Aug 28

Aug 21, 2023 05:31 PM Form S-8 Elicio Therapeutics,

Aug 14, 2023 06:04 AM Form 10-Q Elicio Therapeutics, For: Jun 30

Aug 14, 2023 06:03 AM Form 8-K/A Elicio Therapeutics, For: May 31

Aug 11, 2023 11:43 AM Form 8-K Elicio Therapeutics, For: Aug 11